US2008009060A1PendingUtilityA1

Methods of discovering chemicals capable of functioning as gene expression modulators

Individually held — no corporate assignee on recordPriority: Jul 18, 1989Filed: Feb 8, 2007Published: Jan 10, 2008
Est. expiryJul 18, 2009(expired)· nominal 20-yr term from priority
C07K 14/775C12Q 2600/136C12Q 1/6886C12N 15/67C12Q 1/6897Y02A50/30A61K 31/7068A61K 48/00
65
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides a method of transcriptionally modulating the expression of a gene-of-interest. The method comprises contacting a cell which is capable of expressing the gene with an amount of a molecule effective to transcriptionally modulate expression of the gene and thereby affect the level of the protein encoded by the gene which is expressed by the cell. Molecules useful in the practice of the invention are characterized as follows (a) do not naturally occur in the cell, (b) bind to DNA or RNA or bind to a protein through a domain of such protein which is not a ligand binding domain of a receptor which naturally occurs in the cell. Additionally, this invention provides a method for determining whether a molecule known to be a modulator of protein biosynthesis is capable of transcriptionally modulating expression of a gene-of-interest.

Claims

exact text as granted — not AI-modified
1 - 160 . (canceled)  
     
     
         161 . A method of transcriptionally modulating the expression of a gene of interest in a cell without modulating the expression of other genes in the cell in a way which would cause an adverse effect on a multicellular organism containing the cell, which gene of interest encodes a protein, the expression of which is associated with a defined physiological or pathological effect within the multicellular organism, which comprises contacting a eukaryotic cell which expresses the gene, with a chemical at a concentration effective to specifically transcriptionally modulate expression of the gene and thereby affect the level of the protein encoded by the gene of interest which is expressed by the cell, which chemical: 
 (a) does not naturally occur in the cell,    (b) specifically and directly transcriptionally modulates expression of the gene of interest, and    (c) does not bind to a receptor ligand binding domain, the binding of ligand to which is normally associated with the defined physiological or pathological effect.    
     
     
         162 . The method of  claim 161 , wherein the cell is a cell of the multicellular organism.  
     
     
         163 . The method of claims  161 , wherein the cell is a human cell.  
     
     
         164 . The method of  claim 161 , wherein the gene of interest is a human gene.  
     
     
         165 . The method of  claim 161 , wherein the defined physiological or pathological effect is cancer.  
     
     
         166 . The method of  claim 161 , wherein the defined physiological or pathological effect is diabetes.

Join the waitlist — get patent alerts

Track US2008009060A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.